Preclinical Evaluation of AZ12601011 and AZ12799734, Inhibitors of Transforming Growth Factor β Superfamily Type 1 ReceptorsLindsay C. Spender(Cancer Research UK), Gareth J. Inman(University of Dundee)Molecular PharmacologyNovember 21, 201810.1124/mol.118.112946Cited by 31SaveCiteExport RISWatch citationsRelated PapersAutocrine Bone Morphogenetic Protein-9 Signals through Activin Receptor-like Kinase-2/Smad1/Smad4 to Promote Ovarian Cancer Cell Proliferation|Cancer Research|2009|117BMP9 Is a Proliferative and Survival Factor for Human Hepatocellular Carcinoma Cells|PLoS ONE|2013|77Head and neck cancer incidence is rising but the sociodemographic profile is unchanging: a population epidemiological study (2001–2020)|BJC Reports|2024|36